IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.507
AS - Asia 5.936
EU - Europa 4.869
SA - Sud America 918
Continente sconosciuto - Info sul continente non disponibili 247
AF - Africa 226
OC - Oceania 11
Totale 23.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.125
CN - Cina 2.981
SG - Singapore 1.286
IE - Irlanda 1.075
BR - Brasile 693
DE - Germania 669
UA - Ucraina 645
FI - Finlandia 579
HK - Hong Kong 565
RU - Federazione Russa 506
VN - Vietnam 486
IT - Italia 373
FR - Francia 287
GB - Regno Unito 266
SE - Svezia 241
CA - Canada 165
IN - India 142
ZA - Sudafrica 125
BD - Bangladesh 96
AR - Argentina 78
ID - Indonesia 44
JP - Giappone 44
IQ - Iraq 43
NL - Olanda 40
TR - Turchia 39
MX - Messico 37
CR - Costa Rica 35
ES - Italia 35
BE - Belgio 30
EC - Ecuador 29
CO - Colombia 27
NI - Nicaragua 26
PK - Pakistan 26
IL - Israele 25
PE - Perù 24
PL - Polonia 24
UZ - Uzbekistan 22
VE - Venezuela 21
PH - Filippine 20
PR - Porto Rico 19
JO - Giordania 18
SA - Arabia Saudita 17
EG - Egitto 16
MY - Malesia 16
PY - Paraguay 16
SV - El Salvador 16
CW - ???statistics.table.value.countryCode.CW??? 15
JM - Giamaica 15
TN - Tunisia 15
TT - Trinidad e Tobago 15
CZ - Repubblica Ceca 14
BO - Bolivia 13
GT - Guatemala 13
HN - Honduras 13
MA - Marocco 13
SC - Seychelles 12
CL - Cile 11
LT - Lituania 11
GP - Guadalupe 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
KZ - Kazakistan 8
MU - Mauritius 8
EE - Estonia 7
KE - Kenya 6
RO - Romania 6
AL - Albania 5
AM - Armenia 5
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
MK - Macedonia 5
NP - Nepal 5
SN - Senegal 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
DZ - Algeria 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
KG - Kirghizistan 3
KR - Corea 3
MG - Madagascar 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
SR - Suriname 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
DJ - Gibuti 2
GA - Gabon 2
IS - Islanda 2
Totale 23.439
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
San Jose 1.011
Chandler 894
Jacksonville 850
Ashburn 829
Nanjing 655
Singapore 647
Dallas 630
Hong Kong 551
Council Bluffs 473
Beijing 425
Boardman 327
Nanchang 287
Los Angeles 236
Munich 204
Shenyang 201
Princeton 195
Lauterbourg 190
Lawrence 190
Medford 187
Helsinki 185
Hebei 180
Wilmington 175
Ho Chi Minh City 174
Changsha 172
Jiaxing 162
New York 139
Hanoi 118
Johannesburg 114
Santa Clara 114
Hangzhou 112
Tianjin 102
Ann Arbor 90
Buffalo 90
Redondo Beach 88
Moscow 86
Orem 78
Shanghai 78
São Paulo 76
Atlanta 74
Milan 62
San Francisco 58
Woodbridge 54
Cambridge 53
Montreal 50
Toronto 50
Turku 50
Seattle 48
Phoenix 43
Brooklyn 42
Tokyo 38
Chicago 37
Denver 35
Chennai 34
Piscataway 32
Pavia 28
Brussels 27
Des Moines 26
Fairfield 26
Managua 26
Norwalk 26
Pune 26
Rio de Janeiro 26
San José 26
Frankfurt am Main 25
North Bergen 25
London 24
Boston 23
Columbus 23
Jinan 22
Kunming 21
The Dalles 21
Baghdad 20
Da Nang 20
Stockholm 20
Guangzhou 19
Haiphong 19
Houston 19
Rome 19
Tashkent 19
Verona 18
Ankara 15
Belo Horizonte 15
San Salvador 15
Washington 15
Willemstad 15
Charlotte 14
Falkenstein 14
Quito 14
Trujillo 14
Warsaw 14
Amman 13
Campinas 13
Dhaka 13
Naples 13
Philadelphia 13
Bogotá 12
Orange 12
Taizhou 12
Zhengzhou 12
Totale 14.002
Salva come PNG Salva come JPEG
Nome #
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 1.004
Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention 521
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction 377
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 340
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 295
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 254
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 199
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 172
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 166
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 165
An evaluation of a nutraceutical with berberine, curcumin, inositol, banaba and chromium picolinate in patients with fasting dysglycemia 155
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 155
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 153
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 153
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 149
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 149
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 148
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 148
Abscisic Acid Treatment in Patients with Prediabetes. 148
RAGE : a central player in nondiabetic vascular disease 146
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 145
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 144
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 144
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 142
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 142
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 141
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 141
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 140
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 138
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 138
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 137
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 136
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 136
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 136
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 135
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 133
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 132
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 131
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 129
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 128
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 128
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 127
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 127
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 126
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 125
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 124
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 124
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 123
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 123
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 122
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 122
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 121
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 121
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 121
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 120
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 120
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 119
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 119
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 117
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 116
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 116
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 116
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 115
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 115
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 115
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 115
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 113
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 113
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 113
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 112
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 112
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 112
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 112
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 111
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 110
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 110
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 110
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 109
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 109
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 109
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 108
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 108
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 108
Effects of berberine on lipid profile in subjects with low cardiovascular risk 107
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 107
Candesartan effect on inflammation in hypertension 106
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 106
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 106
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 104
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance 104
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 103
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 102
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 102
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 102
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 102
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 101
A role for quercetin in coronavirus disease 2019 (COVID-19) 100
The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus 100
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 100
Matrix metalloproteinase-2 and – 9 levels in obese patients 99
Totale 14.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022689 0 0 0 0 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20266.710 551 420 831 714 730 272 1.336 305 581 484 312 174
2026/20274.311 1.048 1.168 717 949 429 0 0 0 0 0 0 0
Totale 23.714